Holen Sie sich die Stockscreener-App
2.72
3.03%
0.08
Vorhandelsmarkt:
2.75
0.03
+1.10%
Schlusskurs vom Vortag:
$2.64
Offen:
$2.68
24-Stunden-Volumen:
452.57K
Relative Volume:
1.22
Marktkapitalisierung:
$257.19M
Einnahmen:
$72.76M
Nettoeinkommen (Verlust:
$35.34M
KGV:
7.3653
EPS:
0.3693
Netto-Cashflow:
$-62.91M
1W Leistung:
-0.37%
1M Leistung:
+20.35%
6M Leistung:
+65.85%
1J Leistung:
+98.54%
1-Tages-Spanne:
$2.68
$2.84
1-Wochen-Bereich:
$2.54
$2.84
52-Wochen-Spanne:
$1.23
$3.235
Compugen Ltd Stock (CGEN) Company Profile
Compare CGEN vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CGEN
Compugen Ltd
|
2.72 | 257.19M | 72.76M | 35.34M | -62.91M | 0.3693 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Compugen Ltd Stock (CGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-07 | Eingeleitet | Lake Street | Buy |
| 2026-01-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-13 | Eingeleitet | Oppenheimer | Outperform |
| 2022-08-05 | Herabstufung | Jefferies | Buy → Hold |
| 2020-05-26 | Fortgesetzt | JMP Securities | Mkt Outperform |
| 2020-05-13 | Eingeleitet | Stifel | Buy |
| 2020-05-07 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-22 | Eingeleitet | ROTH Capital | Buy |
| 2020-03-24 | Eingeleitet | SunTrust | Buy |
| 2020-01-16 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-03-29 | Eingeleitet | Oppenheimer | Outperform |
| 2016-02-01 | Fortgesetzt | Oppenheimer | Outperform |
| 2015-10-15 | Eingeleitet | FBR Capital | Outperform |
| 2015-04-23 | Fortgesetzt | Jefferies | Buy |
| 2015-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2014-02-07 | Eingeleitet | MLV & Co | Buy |
| 2009-12-28 | Bestätigt | Cantor Fitzgerald | Buy |
| 2009-07-29 | Eingeleitet | Cantor Fitzgerald | Buy |
Alle ansehen
Compugen Ltd Aktie (CGEN) Neueste Nachrichten
Compugen sets May 18 earnings release, 8:30 AM ET webcast - Stock Titan
Compugen to Release First Quarter 2026 Results on Monday, May 18, 2026 - Yahoo Finance
Compugen’s Stock Run Highlights A One-Time AstraZeneca Deal - Finimize
Insider Selling: Compugen (NASDAQ:CGEN) CEO Sells 5,000 Shares of Stock - MarketBeat
Compugen (CGEN) SVP sells 2,000 shares under 10b5-1 plan - Stock Titan
Compugen (CGEN) CEO exercises options and sells 5,000 Ordinary Shares - Stock Titan
Compugen CEO Anat Cohen-Dayag to transition to executive chair - MSN
Lake Street initiates coverage of Compugen (CGEN) with buy recommendation - MSN
Ophir Eran plans resale of 5,000 shares (Nasdaq: CGEN) - Stock Titan
Affiliate sells and proposes sales at CGEN (NASDAQ: CGEN) — 4,000 shares planned - Stock Titan
What is the outlook for Compugen (CGEN) stock today (Climbs Higher) 2026-04-27Target Price - Newser
Compugen Q1 2025 Earnings Preview - MSN
Compugen (NASDAQ:CGEN) Share Price Crosses Above 200-Day Moving AverageHere's What Happened - MarketBeat
CGEN (Compugen Ltd. Ordinary Shares) posts 161% YoY Q4 2025 revenue growth and massive EPS beat over analyst estimates.Earnings Preview - Cổng thông tin điện tử Tỉnh Sơn La
Compugen (CGEN) Stock: Good Entry Point? (+1.24%) 2026-04-20AI Powered Stock Picks - Cổng thông tin điện tử Tỉnh Sơn La
CGEN SEC FilingsCompugen 10-K, 10-Q, 8-K Forms - Stock Titan
CGEN Insider Sells: Levine Zurit Disposes 2,000 Shares April 16, 2026 - Meyka
Compugen (CGEN) CEO exercises options and sells 5,000 shares under 10b5-1 plan - Stock Titan
[Form 4] COMPUGEN LTD Insider Trading Activity - Stock Titan
Compugen (CGEN) SVP sells 3,125 shares under Rule 10b5-1 plan - Stock Titan
Ophir Eran (CGEN) files to sell 5,000 Ordinary shares under option plan - Stock Titan
CGEN (Nasdaq) Rule 144: 2,000-option shares to be sold; prior 26,375 sale - Stock Titan
Compugen (NASDAQ: CGEN) SVP exercises options, sells 3,125 shares under plan - Stock Titan
Compugen Highlights AI-Driven IO Pipeline, Key Trial Timelines and Big Pharma Partnerships at Needham Conference - MarketBeat
Levine Zurit sells 24,375 CGEN ordinary shares (CGEN) - Stock Titan
Aug Update: Can Compugen Ltd maintain sales growth2026 Volume & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
VIX Spike: Will Compugen Ltd outperform the market in YEARMarket Volume Summary & Weekly Breakout Stock Alerts - baoquankhu1.vn
Eran Perry Net Worth (2026) - GuruFocus
Michelle Mahler Net Worth (2026) - GuruFocus
Savitzky Kinneret Livnat Net Worth (2026) - GuruFocus
Gilead Halevy Net Worth (2026) - GuruFocus
Insider Selling: Compugen (NASDAQ:CGEN) SVP Sells 5,375 Shares of Stock - MarketBeat
Compugen (CGEN) SVP exercises options and sells 7,875 Ordinary Shares - Stock Titan
Aug Update: Whats the analyst consensus on Compugen LtdWeekly Trade Analysis & Smart Allocation Stock Tips - baoquankhu1.vn
Compugen management takes virtual Needham healthcare stage April 13 - Stock Titan
What is the long-term potential of Compugen (CGEN) Stock | Price at $2.46, Up 7.42%Price Target - Newser
Compugen Price Target Announced at $6.00/Share by Lake Street - Moomoo
Compugen (CGEN) Initiates Coverage with 'Buy' Rating by Lake Str - GuruFocus
Compugen (CGEN) Initiates Coverage with 'Buy' Rating by Lake Street | CGEN Stock News - GuruFocus
Compugen (NASDAQ:CGEN) Coverage Initiated by Analysts at Lake Street Capital - MarketBeat
Lake Street Initiates Compugen(CGEN.US) With Buy Rating, Announces Target Price $6 - Moomoo
Compugen (NASDAQ:CGEN) CEO Sells $12,431.25 in Stock - Defense World
Evogene Ltd. (EVGN) stock price, news, quote and history - Yahoo Finance UK
Compugen (CGEN) SVP exercises stock options and sells 3,500 shares under 10b5-1 plan - Stock Titan
Compugen (CGEN) CEO exercises options and sells 5,625 shares in 10b5-1 trade - Stock Titan
Compugen (NASDAQ:CGEN) Stock Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
[144] COMPUGEN LTD SEC Filing - Stock Titan
Finanzdaten der Compugen Ltd-Aktie (CGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.14%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):